دورية أكاديمية

LBA4 - Efficacy and safety of entrectinib in patients with NTRK fusion-positive tumours: Pooled analysis of STARTRK-2, STARTRK-1, and ALKA-372-001

التفاصيل البيبلوغرافية
العنوان: LBA4 - Efficacy and safety of entrectinib in patients with NTRK fusion-positive tumours: Pooled analysis of STARTRK-2, STARTRK-1, and ALKA-372-001
المؤلفون: Demetri, G.D., Paz-Ares, L., Farago, A.F., Liu, S.V., Chawla, S.P., Tosi, D., Kim, E.S., Blakely, C.M., Krauss, J.C., Sigal, D., Bazhenova, L., John, T., Besse, B., Wolf, J., Seto, T., Chow-Maneval, E., Multani, P.S., Johnson, A., Simmons, B., Doebele, R.C.
المصدر: In Annals of Oncology November 2018 29 Supplement 9:ix175-ix175
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09237534
DOI:10.1093/annonc/mdy483.003